Clinical trials: Amblyopia

Amblyopia

Levodopa for the Treatment of Residual Amblyopia

• Completed
• Age: 7 to 12 years
• Phase 3
• Results posted

The purpose of this study is to evaluate the efficacy and safety of oral levodopa and patching versus oral placebo and patching as treatment for residual amblyopia in children 7 to <13 years old with visual acuity of 20/50 to…

Trial name

ATS17 (NCT01190813)

Testing

Levodopa/Carbidopa, Patching

Where

United States

Volunteers

139 people

Sponsor

Jaeb Center for Health Research